Skip to content

Use of Bio-markers in detection of Early Breast Cancer

Effectiveness of Serum miRNA as non- invasive tool in early detection of Carcinoma Breast

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051911
Enrollment
50
Registered
2023-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Serum miRNA sampling: All patients with breast diseases presenting to the department of General Surgery and associated specialties of Breast and Gynecological Oncology will undergo rout

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients presented with both benign and malignant breast conditions. 2. All patients who underwent surgical treatment and have not received radiotherapy and/or chemotherapy

Exclusion criteria

Exclusion criteria: 1. Patient aged less than 18 years 2. Males 3. Patients with auto- immune diseases 4. Patients who received chemotherapy or radiotherapy before operation and co- morbid with other malignancies

Design outcomes

Primary

MeasureTime frame
To compare Serum miRNA and Histopathological report in Breast disease Timepoint: Single pre-operative level at time of first presentation in the Hospital is correlated with post operative histopathology report

Secondary

MeasureTime frame
To study the clinical use of Serum miRNA as a tool in early detection of breast cancerTimepoint: Single Pre-operative level at the time of presentation to the hospital

Countries

India

Contacts

Public ContactGeorge Mathews John

Amrita Institute of Medical Sciences

gmjohn07@gmail.com9633937333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026